Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia Type 2 - A plea to conserve adrenal function

European Journal of Surgery

Volumn 165, Issue 9, 1999, Pages 843-846

  De Graaf, J S ^a,c   Dullaart, R P F ^b   Zwierstra, R P ^a  

^a Department of Surgery ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Addisonian crisis; Adrenalectomy; Complications; Multiple endocrine neoplasia; Phaeochromocytoma

Indexed keywords

ADRENAL CORTEX INSUFFICIENCY; ADRENAL FUNCTION; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SPLENECTOMY; SURGICAL APPROACH; SURGICAL MORTALITY;

ADDISON DISEASE; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 0032888718     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/11024159950189320     Document Type: Article

References (26)

1. 1. Carney JA, Sizemore GW, Sheps SG. Adrenal medullary disease in multiple endocrine neoplasia, type 2. Pheochromocytomas and its precursors. Am J Clin Pathol 1993; 66: 279-290.
2. 2. Carney JA, Sizemore GW, Tyce GM. Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma. Mayo Clin Proc 1975; 50: 3-10.
3. 3. Chalmers RA, Mashiter K, Joplin GF. Residual adrenal cortical function after bilateral "total" adrenalectomy for Cushings disease. Lancet 1981; ii: 1196-1199.
4. 4. Chevinsky AH, Minton JP, Falko JM. Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg 1990; 125: 935-938.
5. 5. Dralle H, Ipta M, Henschel E, et al. Surgical therapy of sporadic and familial pheochromocytoma. Acta Med Austriaca 1988; 15: 108-110.
6. 6. Evans DB, Lee JE, Merell RC, Hickey RC. Adrenal medullary disease in multiple endocrine neoplasia type 2. Endocrin Metab Clinics North Am 1994; 23: 167-176.
7. 7. Freier DT, Thompson NW, Sisson JC, Nishiyama RH, Freitas JE. Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type 2. Surgery 1977; 82: 407-413.
8. 8. Gagel RF, Tashjian AH, Cummings T, et al. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2 A. N Engl J Med 1988; 318: 478-479.
9. 9. Hamberger B, Telenius-Berg M, Cedermark B. Subtotal adrenalectomy in multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 1987; 35: 127-129.
10. 10. Heerden van JA, Sizemore GW, Carney JA, Grant CS, ReMine WH, Sheps SG. Surgical management of the adrenal glands in the multiple endocrine neoplasia syndrome type II syndrome. World J Surg 1984; 8: 612-621.
11. 11. Jansson S, Tisell LE, Fjalling M, Lidberg S, Jacobsson L, Zachrisson BF. Early diagnosis and surgical strategy for adrenal medullary disease in MEN II gene carriers. Surgery 1988; 103: 11-18.
12. 12. Lairmore TC, Ball DW, Baylin SB, Wells SA. Management of pheochromocytomas in patients with multiple endocrine neoplasia Type 2 Syndromes. Ann Surg 1994; 217: 595-603.
13. 13. Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC. Cortical sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 1996; 120: 1064-1071.
14. 14. Lips KJM, van der Sluys Veer J, et al. Bilateral occurence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sippie's syndrome). Am J Med 1981; 70: 1051-1060.
15. 15. Miller WL, Tyrrell JB. The adrenal cortex. In: Felig P, Baxter JD, Frohman LA eds. Endocrinology and metabolism; 3rd ed. McGraw-Hill, New York, 1995: 555-711.
16. 16. Modigliani E, Vasen HM, Raue K, et al. Pheochromocytoma in multiple endocrine neoplasia type 2: European Study. J Intern Med 1995; 238: 236-237.
17. 17. Obara T, Kanbe M, Okamoto T, et al. Surgical strategy for pheochromocytoma: emphasis on the place of flank extra-peritoneal approach in selected patients. Surgery 1995; 118: 1083-1089.
18. 18. Oishi S, Sasaki M, Yamauchi J, et al. Analysis of eight Sipple's syndrome patients and review eighty-two cases from Japanese literature. Jpn J Clin Oncol 1990; 20: 393-294.
19. 19. Shapiro B, Copp JE, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26: 576.
20. 20. Sizemore GW, Carney JA, Gharib H, Capen CC. Multiple endocrine neoplasia type 2b: eighteen year follow-up of a four generation family. Henry Ford Hosp Med J 1992; 40: 236-244.
21. 21. Telenius-Berg M, Ponder MA, Berg B, et al. Quality of life after bilateral adrenalectomy in multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 1989; 37: 160.
22. 22. Tibblin S, Symling JF, Ingermansson S, Telenius-Berg M. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg 1983; 7: 201-206.
23. 23. Vassen HFA, Feltz van der M, Rave F, et al. The natural course of multiple endocrine neoplasia type 2b. Arch Intern Med 1992; 152: 1250-1254.
24. 24. Walz MK, Peitgen K, Saller B, et al. Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 1998; 22: 621-627.
25. 25. Walz MK, Peitgen K, Hoermann R, Giebler RM, Mann K, Eigler FW. Posterior retroperitoneoscopy as a new minimally invasive approach for adrenalectomy. World J Surg 1996; 20: 769-772.
26. 26. Wilson RA, Ibanez ML. A comparative study of 14 cases of familial and non-familial pheochromocytomas. Hum Pathol 1978; 9: 181-188.